David A. Lawrence
State University of New York · 353 works · 22,288 citations · h-index 67
Top works
- Safety and antitumor activity of recombinant soluble Apo2 ligand
- Normal embryo fibroblasts release transforming growth factors in a latent form
- Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions
- Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
- β-Transforming Growth Factor is stored in human blood platelets as a latent high molecular weight complex
- Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
- Further study of β‐tgfs released by virally transformed and non‐transformed cells
- Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
- Dietary fish oil and olive oil supplementation in patients with Rheumatoid Arthritis clinical and immunologic effects
- Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
- Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils.
- Deterministic hydrodynamics: Taking blood apart
- WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors
- Treatment of Male Hypogonadism with Testosterone Enanthate*
- Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
- Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8
- Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling
- Transforming growth factor-beta: a general review.
- Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
- Cells transformed by rous sarcoma virus release transforming growth factors